ResultsIQ › Latest results › Symbiotec Pharmalab Limited
Symbiotec Pharmalab Limited Q1 FY27 results deck summary
NSE: SYMBIOTEC · BSE: 544889
Results deck of 21 Sep 2026, summarised by AI from the filing.
Symbiotec Pharmalab Limited Q1 FY27 results
As filed: Revenue ₹211 cr, EBITDA ₹59.2 cr, PAT ₹47.0 cr, EBITDA margin 28.1%.
Not scored. No result for the same quarter last year.
Symbiotec Pharmalab Limited earnings call, investor presentation and press release summaries
Figures from the company's filings with NSE and BSE. Not investment advice.